Humanized antibody
US7456260B2 · kind B2 · utility
49Cited by
9References
40Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 17, 2003 |
| Grant date | Nov 25, 2008 |
| Priority date | — |
| Expiry date | Jul 17, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The current invention provides new human variable chain framework regions and humanized antibodies comprising the framework regions. The invention also provides a new method of identifying framework acceptor regions in framework sequences for backmutation to graft a donor sequence to the human framework.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.